In 2012 BioGaia initiated a double-blind, placebo-controlled study to investigate the effects of Lactobacillus reuteri Protectis on blood glucose in type 2 diabetics. Despite positive results from an earlier pilot study no significant differences between the groups were seen in this study. Forty-five patients with type 2 diabetes were included in the 12-week long study. The analysis of the results will continue to capitalise on as much knowledge as possible.
Help employers find you! Check out all the jobs and post your resume.
